022 24172311
Sections
Search
DealCurry
Equity
Venture Capital
Private Equity
M&A

Banner
DataBoard Demo
Private Equity | 8 September 2010

Actis, Sequoia Plan Stake Sale In Paras Pharma For $700 Mn

by Deeshesh Chheda
Actis, Sequoia Plan Stake Sale In Paras Pharma For $700 Mn
Share on Social Media Email Facebook Twitter Linkedin
 
@deeshesh

Private equity firms Actis Capital and Sequoia Capital are planning to sell a controlling stake in FMCG company Paras Pharmaceuticals Limited for $700 million.

The private equity firms decided to sell their shares after receiving interest from drugmakers including GlaxoSmithKline, Sanofi-Aventis and Abbott Laboratories.

Actis, a private equity firm that invests in emerging markets, holds about 62% in Paras and Sequoia holds about 8%, while Paras Chairman Girish Patel and employees own the remaining stake.

Transaction Reference: BS


{TAG_9638_1283930409}

Century Real Estate Raises Rs 100 Cr Via NCDs

Century Real Estate Raises Rs 100 Cr Via NCDs

Century Real Estate Holdings, the real estate arm of the Century Group has raised Rs.100 crore though private placement of NCDs last week.

Read More...

Atria Convergence Technologies To Raise Funds From TA Associates and Argan (Mauritius)

Atria Convergence Technologies To Raise Funds From TA Associates and Argan (Mauritius)

Leading global growth private equity firm TA Associates and India Value Fund Advisors’ special purpose vehicle, Argan (Mauritius) are pumping around $500 Mn in high-speed broadband services provider Atria Convergence Technologies for a 95% stake in the company.

Read More...
Subscribe
Enter your Email address
to receive all the news